Anterior ischemic optic neuropathy (AION) is a sudden drop in vision caused by reduced blood flow to the front part of the optic nerve (the “cable” that carries images from your eye to your brain). The small arteries that feed this part of the nerve can become inflamed (in arteritic AION, usually from giant cell arteritis) or under-perfused without inflammation (in non-arteritic AION). Because the optic nerve is crowded in a tight bony tunnel, swelling after ischemia can compress its own fibers and worsen injury, like a “compartment” effect. People typically notice painless, sudden vision loss in one eye, often on waking. AION is most common after age 50. NCBI+2NCBI+2

AION is sudden damage to the front part of the optic nerve (the cable that carries vision from the eye to the brain) because it does not get enough blood. People often wake up with painless vision loss in one eye. Doctors divide it into two main types. Non-arteritic AION (NAION) is the most common and is linked to blood-flow problems and “crowded” optic discs. Arteritic AION (AAION) is caused by inflammation of medium-large arteries, most often from giant cell arteritis (GCA), and is an emergency. Both can cause permanent vision loss. Nature+1

---

Other names

• AAION – arteritic anterior ischemic optic neuropathy (usually due to giant cell arteritis/temporal arteritis). EyeWiki

• NAION – non-arteritic anterior ischemic optic neuropathy (the most common form; no vessel inflammation). EyeWiki+1

• AION – umbrella term for both arteritic and non-arteritic forms. NCBI

---

Types

1) Arteritic AION (AAION).
This form is driven by giant cell arteritis (GCA), an immune-mediated inflammation of medium–large arteries, including the short posterior ciliary arteries that feed the optic nerve head. AAION is an emergency because the other eye may be at risk; urgent steroids are standard care (treatment details not the focus here, but context is important). Fluorescein angiography often shows delayed choroidal filling, a useful clue that points to GCA. EyeWiki+2EyeWiki+2

2) Non-arteritic AION (NAION).
This is the more common type. It is not caused by vessel inflammation but rather by poor perfusion in a structurally crowded optic disc (“disc at risk,” usually a small or absent physiologic cup). Typical risk factors are age >50, hypertension, diabetes, high cholesterol, sleep apnea, and sometimes nocturnal low blood pressure. Vision often drops suddenly and painlessly, frequently noticed on awakening. EyeWiki+2NCBI+2

3) AION in special settings (overlap/variants).
AION features can also appear with optic disc drusen (calcified deposits that crowd the nerve head), or around major systemic stressors (profound anemia, severe blood pressure drops, perioperative settings). These scenarios don’t change the core mechanism—insufficient blood supply to a crowded nerve—but they help explain “why now” in a given patient. PubMed

---

Causes / Risk Factors

Think of “causes” here mainly as risk factors or triggers that make ischemia of the front optic nerve more likely. Some are general vascular risks; others are anatomical or medication-related.

1) Giant cell arteritis (GCA).
Inflammation of the temporal and related arteries in older adults can abruptly cut optic nerve blood flow, causing AAION. Symptoms like new headache, scalp tenderness, or jaw pain while chewing are red flags. EyeWiki+1

2) Crowded optic disc (“disc at risk”).
A small or absent physiologic cup leaves little room; when the nerve swells after ischemia, a “compartment” effect can worsen damage. This anatomy is very common in NAION. EyeWiki

3) Hypertension.
Long-standing high blood pressure damages small vessels and impairs autoregulation, which raises NAION risk. NCBI

4) Diabetes mellitus.
Diabetes injures microvessels and can reduce oxygen delivery, making the optic nerve more vulnerable to ischemia. NCBI

5) Hyperlipidemia.
Elevated cholesterol contributes to vascular disease and small-artery flow problems around the optic disc. NCBI

6) Obstructive sleep apnea (OSA).
OSA causes intermittent nocturnal hypoxia and swings in blood pressure; multiple cohort studies link OSA to higher NAION risk, and untreated OSA may increase future NAION risk. PubMed+1

7) Nocturnal hypotension.
A drop in blood pressure during sleep can reduce optic nerve head perfusion at a time when many patients first notice vision loss on awakening. Wiley Online Library

8) Smoking.
Smoking harms vascular endothelium and blood flow, compounding other risk factors (indirectly supported across NAION vascular risk literature). NCBI

9) Atherosclerotic cardiovascular disease.
Generalized vascular disease (coronary/cerebrovascular) reflects systemic small-vessel risk also relevant to the optic nerve. NCBI

10) Optic disc drusen (ODD).
Buried drusen can crowd the nerve head and are over-represented in younger NAION cohorts; they can lower the age threshold for NAION-like events. PubMed+1

11) Severe anemia or blood loss.
Marked reductions in oxygen-carrying capacity and perfusion pressure can tip a susceptible optic nerve into ischemia (perioperative or systemic hemorrhage contexts). NCBI

12) Perioperative/peri-anesthetic hypotension.
Sustained low pressure around major surgery can under-perfuse the optic nerve, especially in those with crowded discs or vascular comorbidities. (Posterior ION is classically perioperative; similar perfusion concepts apply.) NCBI

13) Phosphodiesterase-5 inhibitors (e.g., sildenafil) in susceptible patients.
A cautionary association exists: regulators recommend caution in individuals with a history of NAION or crowded discs; evidence suggests a possible link in rare cases. FDA Access Data+2PMC+2

14) Amiodarone-associated optic neuropathy.
Amiodarone can produce a slowly progressive, often bilateral optic neuropathy that can mimic NAION and coexist with vascular risks. EyeWiki+1

15) Hypercoagulable states.
Blood conditions that increase clotting or viscosity (e.g., thrombophilias, markedly high hematocrit/platelets) can impair microcirculatory flow to the nerve head. (Mechanistic extrapolation from ischemic microvasculopathy.) NCBI

16) Chronic kidney disease/uremia.
Systemic vascular dysfunction and anemia in advanced kidney disease can worsen optic nerve perfusion risk (reported in NAION cohorts/overviews). NCBI

17) Migraine/vasospasm history.
Transient vascular spasm could theoretically reduce optic nerve head flow in predisposed discs; migraine appears in risk surveys though causation is less clear. NCBI

18) Intraocular pressure/load factors.
While not a glaucoma event, higher pressures and crowded discs may stress perfusion at the lamina/nerve head interface in some eyes. NCBI

19) Systemic inflammatory/autoimmune disease beyond GCA.
Vasculitides and systemic inflammation can raise ischemic risk via vessel injury; GCA is the prototypical example, but others may contribute. NCBI

20) Age >50 years.
Age increases small-vessel disease burden and the prevalence of crowded discs; NAION is most common in this age group. NCBI+1

---

Common Symptoms & Signs

1) Sudden, painless vision loss in one eye.
Most people notice a sudden blur, dim area, or missing part of the visual field—often on waking. Pain is uncommon. AAO

2) “Altitudinal” field loss (top or bottom half missing).
NAION classically causes a horizontal “hemifield” drop (often inferior field), but patterns vary. AAO

3) Washed-out or dulled colors.
Color (especially red) looks less vivid because the optic nerve’s photoreceptor signals are partly blocked by nerve injury. NCBI

4) Decreased visual acuity.
Letters are harder to read; the severity ranges from mild blur to severe loss. NCBI

5) Relative afferent pupillary defect (RAPD).
The affected eye’s pupil reacts sluggishly to light compared with the fellow eye—an objective sign of optic nerve dysfunction. NCBI

6) Swollen optic disc on exam.
In the acute phase, the optic nerve head looks swollen, sometimes with small hemorrhages at the edge. NCBI

7) “Pallid” disc edema in AAION.
When AION is from GCA, the swollen disc can look pale/“chalky,” reflecting severe ischemia. EyeWiki

8) Photopsias or transient dimming.
Brief “gray-outs” can happen early or precede an event (non-specific but reported). NCBI

9) Headache, scalp tenderness (GCA clues).
New headaches, scalp pain when combing hair, or jaw pain while chewing suggest arteritic disease. EyeWiki

10) Jaw claudication (GCA clue).
Chewing pain from ischemic jaw muscles is highly suggestive of GCA in older adults. EyeWiki

11) Systemic symptoms in AAION.
Fever, fatigue, weight loss, or shoulder/hip aching (polymyalgia rheumatica) can accompany GCA. EyeWiki

12) Vision loss in the other eye (risk).
Without prompt recognition and treatment of GCA, the fellow eye can be threatened within days. NAION also carries a smaller fellow-eye risk over time. EyeWiki+1

13) Poor contrast sensitivity.
Faint or low-contrast targets seem much harder to see than high-contrast letters. NCBI

14) Decreased reading endurance.
Sustained near work may feel tougher due to field defects and contrast loss. NCBI

15) Often no eye pain, redness, or discharge.
AION is typically painless and “quiet,” which helps differentiate it from many inflammatory eye diseases. AAO

---

Diagnostic Tests

A) Physical Examination

1) Best-corrected visual acuity.
Checking line-by-line acuity quantifies how much central vision is affected and guides baseline tracking. AAO

2) Confrontation visual fields.
Bedside field testing maps obvious missing areas; later, automated fields quantify the pattern (e.g., altitudinal loss). AAO

3) Color vision plates (Ishihara or similar).
Color desaturation (especially red) is common in optic nerve disease; plates detect subtle deficits. NCBI

4) Pupil exam with swinging flashlight test.
This detects a relative afferent pupillary defect, a hallmark of unilateral/unequal optic nerve dysfunction. NCBI

5) Fundus examination (dilated).
Ophthalmoscopy looks for swollen optic disc, peripapillary hemorrhages, and later optic atrophy; AAION often shows pallid edema. EyeWiki+1

6) Blood pressure measurement (including nocturnal history).
Documenting hypertension and discussing nighttime dips helps uncover perfusion factors linked to NAION. NCBI+1

B) Manual Bedside Tests

7) Amsler grid.
A simple grid can reveal central distortions or scotomas patients notice at home or in clinic. (Supportive tool; not diagnostic alone.) NCBI

8) Temporal artery palpation.
In suspected GCA, a tender, thickened, or pulseless temporal artery heightens suspicion for AAION and pushes urgent labs/biopsy. EyeWiki

9) Eye pressure (tonometry).
While AION is not primarily a pressure disease, documenting intraocular pressure helps rule out mimickers and assess overall eye health. NCBI

10) Visual field confrontation by quadrants.
Hands-on perimetry helps localize an altitudinal pattern before formal automated perimetry. AAO

C) Laboratory / Pathology Tests

11) ESR (erythrocyte sedimentation rate).
Elevated ESR supports GCA; a normal value does not fully exclude it but helps triage urgency alongside symptoms. NCBI

12) CRP (C-reactive protein).
CRP rises in active inflammation and often complements ESR in GCA work-ups. NCBI

13) Complete blood count with platelets.
Thrombocytosis can accompany GCA; anemia or other anomalies can reveal systemic contributors like blood loss. NCBI

14) Temporal artery biopsy (TAB).
This is the gold standard for confirming GCA: segmental granulomatous vasculitis with giant cells and disrupted internal elastic lamina. Sampling length matters because “skip” lesions occur. NCBI+1

15) Metabolic/vascular profile (glucose, lipids).
Identifying diabetes and hyperlipidemia is important because they are strong NAION risk factors and need long-term control. NCBI

D) Electrodiagnostic Tests

16) Visual evoked potentials (VEP).
VEP measures the brain’s electrical response to visual patterns. In optic neuropathies, signals are delayed or reduced; VEP helps document optic nerve dysfunction and can aid differentiation from retinal or post-chiasmal problems. NCBI+1

17) Multifocal or pattern VEP variants.
mfVEP can map localized defects and sometimes help distinguish optic neuritis from ischemic neuropathy; it’s supportive rather than definitive. PMC+1

E) Imaging Tests

18) Optical coherence tomography (OCT).
OCT measures retinal nerve fiber layer (RNFL) and ganglion cell layer thickness. In acute AION, RNFL is swollen; weeks later, RNFL and ganglion cell complex thin as atrophy sets in. OCT can also show occasional subretinal fluid in NAION and, in some cases, subtle early swelling in the fellow eye (an “impending” sign). PMC+2aes.amegroups.org+2

19) Fluorescein angiography (FA) and, selectively, OCT-A.
In AAION/GCA, FA often shows delayed choroidal filling, a classic sign that points to posterior ciliary artery involvement; in NAION, choroidal filling is typically normal or only minimally altered. OCT-angiography can reveal reduced peripapillary capillary density during acute edema. EyeWiki+3Lippincott Journals+3Ajo+3

20) Vascular/structural imaging for GCA or mimics.
Color duplex ultrasound may show a “halo sign” in temporal arteries; MRI of the orbits/brain helps exclude other optic nerve causes (e.g., optic neuritis, compressive lesions) when the picture is atypical. High-resolution vessel wall imaging can support large-vessel GCA assessment in some centers. EyeWiki

Non-pharmacological treatments

Each item includes: short description, purpose, and mechanism/why it helps.

1. Immediate rule-out of GCA (arteritic AION)
   If a person over ~50 has sudden vision loss with headache, scalp tenderness, or jaw pain, doctors treat at once for GCA with high-dose steroids while arranging tests. Purpose: protect the other eye. Mechanism: quickly reduces artery inflammation to restore blood flow. PMC+1

2. Optimize blood pressure (avoid night-time over-lowering)
   Very low blood pressure at night may reduce optic nerve perfusion. Purpose: avoid dips that could trigger NAION. Mechanism: maintaining adequate nocturnal perfusion to the optic nerve head. Nature

3. Tight diabetes control (gradual and safe)
   Stable, safe glucose levels support small-vessel health; avoid rapid changes. Purpose: reduce microvascular injury. Mechanism: less glycation and arteriolar damage to optic nerve blood supply. NCBI

4. Treat obstructive sleep apnea (OSA), usually with CPAP
   OSA is strongly linked to NAION; CPAP use may reduce risk in the fellow eye. Purpose: improve oxygenation and stabilize blood pressure swings at night. Mechanism: fewer nocturnal hypoxia/hypotension events. PMC+2PubMed+2

5. Stop smoking
   Smoking injures blood vessels and worsens vascular risk. Purpose: reduce future events. Mechanism: improves endothelial function and oxygen delivery. AAO

6. Manage cholesterol and overall cardiovascular risk (with your physician)
   Purpose: support healthy small arteries that feed the optic nerve. Mechanism: reduces atherosclerosis and improves perfusion. (Use medications only as your doctor directs.) AAO

7. Medication review (avoid or rethink certain drugs after NAION)
   Discuss PDE-5 inhibitors (sildenafil, etc.) and amiodarone with your doctors; some reports link them to NAION or NAION-like optic neuropathy. Purpose: remove possible triggers. Mechanism: reduces potential optic nerve hypoperfusion or toxicity. nanosweb.org

8. Manage anemia and kidney disease
   Low oxygen-carrying capacity and uremia can impair optic nerve perfusion. Purpose: improve systemic oxygen delivery. Mechanism: supports microvascular supply to the nerve. nanosweb.org

9. Healthy weight and regular, moderate exercise
   Purpose: better vascular health, sleep, and blood pressure. Mechanism: improves endothelial function and reduces insulin resistance. AAO

10. Hydration and illness planning
    Avoid prolonged dehydration or hypotension (for example during illness or major surgery) which may reduce optic nerve blood flow. Purpose: maintain perfusion. Mechanism: adequate intravascular volume. Nature

11. Sleep hygiene
    Consistent sleep supports OSA management and cardiovascular control. Purpose: fewer desaturations and BP swings. Mechanism: steadier autonomic tone overnight. PMC

12. Vision rehabilitation (low-vision services)
    Early referral improves function and independence. Purpose: teach strategies, devices, and lighting for daily tasks. Mechanism: compensates for blind spots with aids and training. Nature

13. Lighting and glare control at home/work
    Purpose: reduce visual strain and improve contrast sensitivity. Mechanism: bright, even task lighting and filters boost usable vision. Nature

14. Driving safety counseling
    Purpose: prevent accidents if field loss affects safety; follow local rules. Mechanism: adapt driving or stop until assessed. Nature

15. Falls-prevention and home modifications
    Purpose: reduce injury risk due to field loss. Mechanism: remove trip hazards, add handrails, increase contrast at steps. Nature

16. Occupational therapy
    Purpose: improve reading, technology use, and work tasks with low-vision adaptations. Mechanism: task-specific training and device matching. Nature

17. Psychological support
    Sudden vision loss is stressful. Purpose: reduce anxiety/depression; support coping. Mechanism: counseling and peer support improve quality of life. Nature

18. Regular follow-up and monitoring of the fellow eye
    Purpose: watch for changes; reinforce OSA and risk-factor control which lower bilateral risk. Mechanism: early detection and adherence support. PubMed

19. Educate about “wake-up vision loss”
    Many patients notice NAION on waking. Purpose: seek care promptly if new symptoms occur. Mechanism: faster AAION rule-out and support. Nature

20. Team approach (eye doctor + primary care + sleep/heart specialists)
    Purpose: treat whole-body risks that affect the optic nerve. Mechanism: coordinated care for BP, lipids, diabetes, OSA, and meds. AAO

---

Drug treatments

For NAION there is no proven medical treatment that reliably restores vision. Some drugs are vital for AAION/GCA. Others are used for general vascular protection. A few have inconclusive or negative evidence in NAION. Always use medicines only under your clinician’s advice.

1. High-dose corticosteroids for AAION (GCA)
   This is urgent and life-saving for vision. Typical practice is prednisone 40–60 mg/day (or IV methylprednisolone if visual symptoms are present) while arranging biopsy within a week. Purpose: stop artery inflammation and protect the other eye. Mechanism: suppresses immune attack on arteries. Common side effects: high sugar, mood change, insomnia, infection risk, bone loss. Medscape+1

2. Aspirin (systemic, vascular prevention)
   Aspirin does not restore vision in NAION. Studies on preventing fellow-eye NAION have mixed results; some suggest a short-term reduction, others find no clear benefit, and experts caution against recommending it solely for NAION prevention. Purpose: systemic vascular risk reduction if indicated by your doctor. Side effects: bleeding, stomach upset. PubMed+2PMC+2

3. Statins (lipid-lowering)
   Not a treatment for NAION itself, but may be used to meet cardiovascular goals. Purpose: reduce vascular events. Side effects: muscle aches, rare liver enzyme rise; dosing individualized. AAO

4. Antihypertensives (careful nighttime strategy)
   Good BP control is important, but very low “nocturnal dips” may be risky for NAION. Purpose: balanced BP control. Side effects depend on class (e.g., dizziness). Dosing and timing should be set by your clinician. Nature

5. Diabetes medicines (gradual, safe control)
   Glycemic control protects vessels. Recent large human studies suggest semaglutide (a GLP-1 RA) may be associated with higher NAION risk; discuss options with your doctor. Purpose: safe glucose targets without rapid swings. Side effects: vary by drug. JAMA Network+1

6. CPAP (device, not a drug, but often prescribed)
   It treats OSA, a strong NAION risk factor. Purpose: fewer oxygen drops and BP swings at night; may lower fellow-eye risk if used consistently. Side effects: mask discomfort. PubMed

7. Anticoagulants
   Not used to treat NAION unless another condition requires them (e.g., atrial fibrillation). Purpose: treat the other condition. Side effects: bleeding. Nature

8. Brimonidine (eye drop) / IOP-lowering agents
   Tried for “neuroprotection,” but controlled data do not show benefit in NAION. Purpose: none proven for NAION. Side effects: eye redness, fatigue. Frontiers

9. Intravitreal anti-VEGF injections
   Helpful in many retinal diseases, but studies did not show benefit in NAION. Purpose: none proven for NAION. Risks: injection-related complications. Frontiers

10. Hyperbaric oxygen
    Evidence does not support routine use in NAION. Purpose: none proven. Side effects: barotrauma, claustrophobia. Frontiers

11. Systemic corticosteroids for NAION (non-arteritic)
    Randomized evidence is lacking; expert reviews do not recommend steroids for NAION because benefit is unproven and risks are real. Purpose: none proven. Side effects: as above. BioMed Central

12. Pentoxifylline / vasodilators
    Small or uncontrolled reports exist, but no convincing benefit for NAION. Purpose: none proven. Side effects: GI upset, dizziness. Dove Medical Press

13. Erythropoietin (EPO)
    Explored as a neuroprotective agent; evidence is insufficient for routine care. Purpose: experimental. Risks: thrombosis, hypertension. Dove Medical Press

14. Citicoline / neurotrophic supplements
    Proposed to support nerve cells, but not proven for NAION. Purpose: none established. Side effects: mild GI or headache. Dove Medical Press

15. Topical or systemic carbonic anhydrase inhibitors
    These lower intraocular pressure but do not treat NAION. Purpose: none for NAION. Side effects: tingling, taste change (systemic). BioMed Central

16. Corticosteroid-sparing agents for GCA (e.g., tocilizumab, methotrexate)
    Used by rheumatologists to reduce steroid exposure in GCA after vision is stabilized. Purpose: maintain remission with fewer steroid side effects. Risks depend on drug (infection risk, labs monitoring). The Open Rheumatology Journal

17. Pain control (acetaminophen)
    AION is usually painless, but safe pain control may be used for associated headaches (not as NAION therapy). Purpose: comfort only. Nature

18. Proton-pump inhibitors or bone protection when on long steroids for GCA
    Purpose: reduce stomach bleeding and bone loss from steroids. Mechanism: acid suppression; calcium/vitamin D±bisphosphonate per doctor. PMC

19. Smoking-cessation aids (varenicline, NRT) as indicated
    Purpose: help quit smoking to protect vessels. Risks: vary by product; use with clinician advice. AAO

20. Vaccinations while on long-term immunosuppression for GCA
    Purpose: reduce infection risk. Plan with your care team. PMC

---

Dietary molecular supplements

There is no supplement proven to treat NAION or restore vision. Some people use supplements for general vascular health. These ideas are adjuncts only and should be discussed with your doctor (to avoid drug interactions). BioMed Central

1. Omega-3 fatty acids (fish oil)
   General vascular support is plausible, but not NAION-specific. Possible GI upset or bleeding at high doses; dosing individualized. BioMed Central

2. Vitamin D (if deficient)
   Correcting deficiency supports bone and immune health; no NAION-specific data. Avoid excess. BioMed Central

3. Vitamin B12 (if deficient)
   Treating deficiency can help the nervous system; NAION-specific benefit not shown. BioMed Central

4. Folate/B-complex to lower homocysteine (if elevated)
   Helps general vascular risk profiles; not proven for NAION. BioMed Central

5. Coenzyme Q10
   Popular for mitochondrial support; no NAION evidence. BioMed Central

6. Magnesium (sleep/vascular tone, if low)
   May aid sleep and cramps; NAION data absent. Avoid excess. BioMed Central

7. Lutein/zeaxanthin
   Retinal antioxidants help macular health; no proof in NAION. BioMed Central

8. Alpha-lipoic acid
   Antioxidant sometimes used in neuropathy; NAION data lacking. BioMed Central

9. Resveratrol
   Vascular antioxidant in lab studies; human NAION data lacking. BioMed Central

10. Probiotics (gut-metabolic health)
    General metabolic and inflammation effects are being studied; no NAION evidence. BioMed Central

---

Immunity-booster / regenerative / stem-cell drugs

No immune-booster, stem-cell, or regenerative drug is approved to treat NAION. Research is exploring future neuroprotection and regeneration, but these remain experimental and should be used only in clinical trials. PMC

1. Experimental stem-cell neuroprotection
   Concept: replace or support damaged retinal ganglion cells. Status: experimental; risks include inflammation and retinal complications. PMC

2. Growth-factor approaches (e.g., CNTF, BDNF analogs)
   Concept: protect optic nerve cells after ischemia. Status: preclinical/early studies only. PMC

3. Remyelination/neuro-repair strategies
   Concept: improve axon function after injury. Status: early research. PMC

4. Mitochondrial-targeted therapies
   Concept: support energy supply in stressed optic nerve cells. Status: research stage. PMC

5. Anti-inflammatory biologics (beyond steroids) for GCA
   Used to reduce steroid burden in GCA maintenance, not to reverse NAION. Requires specialist care. The Open Rheumatology Journal

6. Gene-based neuroprotection
   Concept: deliver genes that help cells resist ischemia. Status: experimental only. PMC

---

Procedures / surgeries

1. Temporal artery biopsy (TAB)
   This is a small surgical procedure to confirm GCA when AAION is suspected. It does not treat vision, but it proves the diagnosis so doctors can guide long-term therapy. PMC

2. Optic nerve sheath decompression surgery (ONDS)
   Once tried for NAION. The IONDT randomized trial showed no benefit and possible harm, so this operation is not recommended. PubMed+1

3. Hyperbaric oxygen therapy
   A procedure in a pressurized chamber that increases dissolved oxygen in the blood. Studies have not shown benefit in NAION; it’s not standard care. Frontiers

4. Carotid or heart procedures (only if you have separate indications)
   Some people with serious carotid disease or heart rhythm problems need procedures for stroke prevention. These do not treat NAION itself but may be advised for general health by other specialists. Nature

5. Low-vision device fitting (clinical procedure, not surgery)
   Specialists can prescribe magnifiers, electronic readers, filters, and training. This improves daily functioning after NAION. Nature

---

Prevention tips

1. Treat GCA immediately if suspected to protect the other eye. PMC

2. Control blood pressure without excessive night-time lowering. Nature

3. Keep diabetes well controlled (avoid rapid swings). NCBI

4. Treat sleep apnea and use CPAP as prescribed. PubMed

5. Stop smoking. AAO

6. Manage cholesterol and overall heart risk with your doctor. AAO

7. Review medicines after NAION (PDE-5 inhibitors, amiodarone) with your doctors. nanosweb.org

8. Avoid dehydration and severe hypotension, especially during illness or surgery. Nature

9. Keep regular eye and medical follow-ups. PubMed

10. Learn warning signs of new vision loss and seek prompt care. Nature

---

When to see a doctor

See an eye doctor immediately for sudden, painless loss of vision in one eye, especially on waking. Go urgently if you also have headache, scalp tenderness, jaw pain when chewing, fever, weight loss, or shoulder/hip aches—these can signal GCA and threaten the other eye. Also seek care for new vision changes in the remaining eye, or if you struggle to use CPAP or control BP, sugar, or lipids. Nature+1

---

What to eat and what to avoid

Eat: a Mediterranean-style pattern—vegetables, fruits, whole grains, legumes, nuts, fish; use olive oil; choose lean proteins; keep good hydration. Purpose: support heart and vessel health that also supplies the optic nerve. Nature

Avoid or limit: tobacco, heavy alcohol, high-salt ultra-processed foods, large nighttime BP drops from uncoordinated meds (talk to your doctor), and after NAION discuss avoiding PDE-5 inhibitors and amiodarone with your care team. Purpose: reduce vascular stress and potential triggers. AAO+1

---

FAQs

1. Can lost vision come back?
   Some people improve a little over months, but many have permanent loss. There is no proven therapy to restore NAION vision. BioMed Central

2. What’s the main difference between NAION and AAION?
   NAION is vascular/structural; AAION is due to inflamed arteries (GCA) and is an emergency needing high-dose steroids. PMC

3. Why do many people notice it on waking?
   Night-time BP dips and OSA-related events may reduce optic nerve perfusion. Nature

4. Does aspirin help?
   Aspirin doesn’t restore vision; studies on preventing second-eye NAION are mixed and expert guidance is not to recommend it solely for that reason. WashU Research Profiles

5. What about steroid pills for NAION?
   For NAION, routine steroids are not recommended; for AAION (GCA) steroids are essential and urgent. BioMed Central+1

6. Is there a surgery that fixes NAION?
   No. The IONDT proved optic nerve sheath decompression does not help and may harm. PubMed

7. Should I change my blood pressure pills?
   Do not change on your own. Ask your doctor about timing and targets to avoid night-time over-lowering. Nature

8. Does sleep apnea really matter?
   Yes. OSA is strongly linked to NAION; staying on CPAP may lower risk to the other eye. PubMed

9. Can medications trigger NAION?
   Some reports link erectile-dysfunction pills and amiodarone; review risks with your doctors. nanosweb.org

10. Are GLP-1 weight-loss/diabetes shots linked to NAION?
    Large studies suggest an association with semaglutide; discuss benefits and risks with your clinician. JAMA Network

11. Will vitamins or supplements help my vision?
    No supplement has proven benefit for NAION. Focus on overall vascular health and doctor-guided care. BioMed Central

12. What is the chance the other eye is affected?
    Risk varies; good control of risks (especially OSA with CPAP) may lower fellow-eye risk. PubMed

13. Can I keep driving?
    It depends on your visual field and local laws. Get a formal assessment and consider low-vision rehab. Nature

14. Is there active research?
    Yes—neuroprotection, mitochondria-targeted drugs, regenerative and stem-cell approaches—but none are approved yet. PMC

15. Bottom line for NAION?
    Act fast to rule out AAION/GCA, then focus on vascular risk control, OSA treatment, smoking cessation, medication review, and low-vision rehab. BioMed Central

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 19, 2025.